| For: | Filipiuk A, Gonciarz M. Rare extraintestinal manifestations of ulcerative colitis treated with dual biologic therapy: A case report. World J Clin Cases 2024; 12(23): 5441-5447 [PMID: 39156084 DOI: 10.12998/wjcc.v12.i23.5441] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i23/5441.htm |
| Number | Citing Articles |
| 1 |
Shellie Radford, Daniel Arruda Navarro Albuquerque, Zara Najeeb, Debangsh Agarwal, Anoop John, Morris Gordon, Vassiliki Sinopoulou, Gordon Moran. Safety and efficacy of advanced combination therapies for treating inflammatory bowel disease in adults: a systematic review and meta-analysis. BMJ Open Gastroenterology 2026; 13(1) doi: 10.1136/bmjgast-2026-002307
|
| 2 |
|
| 3 |
Javier P Gisbert, María Chaparro. Combination therapy with biologics and/or small molecules in inflammatory bowel disease: a comprehensive review. Journal of Crohn's and Colitis 2025; 19(9) doi: 10.1093/ecco-jcc/jjaf161
|
| 4 |
Fattaneh Sabzehali, Verena Zerbato, Stefano Di Bella, Stefano Morabito, Mohammad Reza Zali, Abbas Yadegar. Unraveling the Pathogenetic Potential and Immune Crosstalk of Yersinia spp. in Inflammatory Bowel Disease. Journal of Immunology Research 2026; 2026(1) doi: 10.1155/jimr/2846665
|
| 5 |
Jonathan Soldera, Maria Antonia Selbach Pertile, Leticia Nodari Carobin, Daniel Jun Funatsu Brambilla, Eduardo Brambilla. Beyond class switching in multi-refractory inflammatory bowel disease: Nine case reports and review of literature. World Journal of Gastrointestinal Pharmacology and Therapeutics 2026; 17(3): 120771 doi: 10.4292/wjgpt.120771
|